Thomas Cook, Ph.D.
Affiliations: | Northwestern University, Evanston, IL |
Google:
"Thomas Cook"Mean distance: 20.73 (cluster 20)
Children
Sign in to add trainee| Fred B. Bryant | grad student | Northwestern | |
| Melvin M. Mark | grad student | Northwestern | |
| Kathleen McGraw | grad student | (PoliSci Tree) | |
| Richard L Miller | grad student | 1971-1975 | Northwestern (PsychTree) |
| Regina J. Deil-Amen | grad student | 2002 | Northwestern |
| Robert F. Murphy | grad student | 2002 | Northwestern |
| Monique R. Payne | grad student | 2004 | Northwestern |
| William J. Corrin | grad student | 2009 | Northwestern |
| Lori A. Delale-O'Connor | grad student | 2011 | Northwestern |
| Kelly Hallberg | grad student | 2013 | Northwestern |
Collaborators
Sign in to add collaborator| Donald "Don" Thomas Campbell | collaborator | ||
| Carla Groom | collaborator | 2000-2003 | Northwestern (PsychTree) |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Johnston P, Duckers E, Raval A, et al. (2018) TCT-747 The CardiAMP Heart Failure Study: First Results from Unblinded Roll-In Phase Journal of the American College of Cardiology. 72 |
| Hallberg K, Cook TD, Steiner PM, et al. (2016) Pretest Measures of the Study Outcome and the Elimination of Selection Bias: Evidence from Three Within Study Comparisons. Prevention Science : the Official Journal of the Society For Prevention Research |
| Ambrosy AP, Pang PS, Khan S, et al. (2013) Clinical course and predictive value of congestion during hospitalization in patients admitted for worsening signs and symptoms of heart failure with reduced ejection fraction: findings from the EVEREST trial. European Heart Journal. 34: 835-43 |
| Blair JE, Pang PS, Schrier RW, et al. (2011) Changes in renal function during hospitalization and soon after discharge in patients admitted for worsening heart failure in the placebo group of the EVEREST trial. European Heart Journal. 32: 2563-72 |
| Wang NC, Piccini JP, Konstam MA, et al. (2010) Implantable cardioverter-defibrillators in patients hospitalized for heart failure with chronically reduced left ventricular ejection fraction. American Journal of Therapeutics. 17: e78-87 |
| O'Connor CM, Miller AB, Blair JE, et al. (2010) Causes of death and rehospitalization in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction: results from Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study with Tolvaptan (EVEREST) program. American Heart Journal. 159: 841-849.e1 |
| Pang PS, Zannad F, Konstam M, et al. (2010) 40: Changes In the Neurohormonal Profile of Patients Hospitalized for Acute Heart Failure Syndromes During the Early Post-Discharge Period According to Early, Late, or No Heart Failure Re-Hospitalization or Mortality Events: Analysis From the EVEREST Trials Annals of Emergency Medicine. 56 |
| Blair JEA, Zannad F, Konstam MA, et al. (2008) Continental Differences in Clinical Characteristics, Management, and Outcomes in Patients Hospitalized With Worsening Heart Failure. Results From the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan) Program Journal of the American College of Cardiology. 52: 1640-1648 |
| Wang NC, Maggioni AP, Konstam MA, et al. (2008) Clinical implications of QRS duration in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction. Jama. 299: 2656-66 |
| Wang NC, Maggioni AP, Konstam MA, et al. (2008) 246 Clinical implications of the QRS duration in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction: Results from the EVEREST program European Journal of Heart Failure Supplements. 7: 58-58 |